Regulon

Regulon: R-869

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
20-1.2093510Pr-62Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
2065 ENSG00000065361 ERBB3 P21860
1400 ENSG00000072832 CRMP1 Q14194
7155 ENSG00000077097 TOP2B Q02880
1627 ENSG00000113758 DBN1 Q16643
51421 ENSG00000114019 AMOTL2 Q9Y2J4
23046 ENSG00000116852 KIF21B O75037
4821 ENSG00000125820 NKX2-2 O95096
57110 ENSG00000127252 HRASLS Q9HDD0
3232 ENSG00000128652 HOXD3 P31249
56934 ENSG00000154975 CA10 Q9NS85
9844 ENSG00000155849 ELMO1 Q92556
9162 ENSG00000157680 DGKI O75912
3516 ENSG00000168214 RBPJ Q06330
90362 ENSG00000169122 FAM110B Q8TC76
214 ENSG00000170017 ALCAM Q13740
55636 ENSG00000171316 CHD7 Q9P2D1
7368 ENSG00000174607 UGT8 Q16880
6664 ENSG00000176887 SOX11 P35716
6304 ENSG00000182568 SATB1 Q01826
4661 ENSG00000276876 MYT1 Q01538

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
POZIOTINIBERBB2Small moleculeINHIBITOREpidermal growth factor receptor inhibitor20
MM-111ERBB2UnknownINHIBITORErbB-2/ErbB-3 heterodimer inhibitor20
DEXRAZOXANETOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor40
DULIGOTUZUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor20
ZENOCUTUZUMABERBB2AntibodyINHIBITORErbB-2/ErbB-3 heterodimer inhibitor20
BECATECARINTOP1Small moleculeINHIBITORDNA topoisomerase II inhibitor30
PRALUZATAMAB RAVTANSINEALCAMAntibodyINHIBITORTubulin inhibitor20
SAPITINIBEGFRSmall moleculeINHIBITORReceptor protein-tyrosine kinase erbB-2 inhibitor20
AMG-888ERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor20
ELGEMTUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor10
ISTIRATUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor20
TENIPOSIDETOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor40
KBP5209ERBB2UnknownINHIBITOREpidermal growth factor receptor inhibitor10
TARLOXOTINIBERBB2Small moleculeINHIBITOREpidermal growth factor receptor inhibitor20
AV-203ERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor10
VANDETANIBEPHA2Small moleculeINHIBITORTyrosine-protein kinase SRC inhibitor42
PATRITUMAB DERUXTECANTOP1AntibodyINHIBITORDNA topoisomerase I inhibitor20
BERUBICINTOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor22
AMSACRINETOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor40
VOSAROXINTOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor30
BERUBICIN HYDROCHLORIDETOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor21
MM-121ERBB3AntibodyANTAGONISTReceptor tyrosine-protein kinase erbB-3 antagonist20
PAZUFLOXACINTOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor30
PATRITUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor30
SERIBANTUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor20
ETOPOSIDETOP2ASmall moleculeINHIBITORDNA topoisomerase II inhibitor42
CDX-3379ERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor20
LUMRETUZUMABERBB3AntibodyINHIBITORReceptor tyrosine-protein kinase erbB-3 inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-869

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs